Vanberra Signal

Pocket Diagnostics

Curated by Signal

Developer of molecular diagnostic devices for at-home and point-of-care settings

Overview

Developer of molecular diagnostic devices for at-home and point-of-care settings. It offers Electrochemical Impedance Spectroscopy platform technology delivering lab-quality diagnostic testing in Point-of-Care and At-Home settings to detect any biomolecule using the vast majority of sample types.

Key facts

Founded
2023

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online platform offering non-urgent consultation to avail prescription

    Health TechnologyLondon, United Kingdom
  • Provider of an AI and cloud-based neurodegenerative diseases analysis platform for providers

    Health TechnologyLondon, United Kingdom
  • Digital telehealth and listing platform for aesthetic professionals and patients

    Health TechnologyHereford, United Kingdom

About Pocket Diagnostics

What does Pocket Diagnostics do?

Developer of molecular diagnostic devices for at-home and point-of-care settings.

Where is Pocket Diagnostics headquartered?

Pocket Diagnostics is headquartered in London, United Kingdom.

When was Pocket Diagnostics founded?

Pocket Diagnostics was founded in 2023.

Which sector is Pocket Diagnostics in?

Pocket Diagnostics operates in Health Technology.

Who are Pocket Diagnostics's competitors?

Companies similar to Pocket Diagnostics include The Online Clinic, Avalon AI, and Glowery.